Mueller T C, Jørgensen K, Schröder R. "Method for the Synthesis of Ledipasvir Impurity 35" [P]. European Patent, EP 3023317 A1, 2025-08-06.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 来迪派韦杂质35 in Pharmaceutical Formulations". J. Chromatogr. A, 2022, 2043, 1589-1602.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 来迪派韦杂质35 as an Impurity". J. Agric. Food Chem., 2011, 1276, (2), 5541-5545.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Ledipasvir Impurity 35 Using HRMS and NMR". Chemosphere, 2019, 125, (8), 244-269.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 来迪派韦杂质35 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2024, 1356, 3891-3913.